Bilcare Ltd BSE receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Metrics to compare | BIL | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipBILPeersSector | |
|---|---|---|---|---|
P/E Ratio | 85.0x | 17.3x | −0.4x | |
PEG Ratio | 0.80 | 0.02 | 0.00 | |
Price/Book | 0.7x | 1.1x | 2.6x | |
Price / LTM Sales | 0.2x | 2.2x | 3.0x | |
Upside (Analyst Target) | - | 29.7% | 51.9% | |
Fair Value Upside | Unlock | 13.1% | 9.4% | Unlock |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.